Quantum Genomics (STU:2QG) Days Payable : 79.21 (As of Dec. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Quantum Genomics Days Payable?

Quantum Genomics's average Accounts Payable for the six months ended in Dec. 2022 was €10.85 Mil. Quantum Genomics's Cost of Goods Sold for the six months ended in Dec. 2022 was €25.00 Mil. Hence, Quantum Genomics's Days Payable for the six months ended in Dec. 2022 was 79.21.

The historical rank and industry rank for Quantum Genomics's Days Payable or its related term are showing as below:

STU:2QG's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.78
* Ranked among companies with meaningful Days Payable only.

Quantum Genomics's Days Payable increased from Dec. 2021 (75.53) to Dec. 2022 (79.21). It may suggest that Quantum Genomics delayed paying its suppliers.

Quantum Genomics Days Payable Historical Data

The historical data trend for Quantum Genomics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Days Payable Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

137.20

187.38

128.96

126.96

141.11

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Days Payable	Get a 7-Day Free Trial															113.16	460.02	75.53	253.45	79.21

Competitive Comparison of Quantum Genomics's Days Payable

For the Biotechnology subindustry, Quantum Genomics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quantum Genomics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum Genomics's Days Payable distribution charts can be found below:

* The bar in red indicates where Quantum Genomics's Days Payable falls into.

Quantum Genomics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Quantum Genomics's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (6.803	+	16.008)	/	2 )	/	29.502	*	365
=	11.4055					/	29.502	*	365
=	141.11

Quantum Genomics's Days Payable for the quarter that ended in Dec. 2022 is calculated as:

	Days Payable (Q: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2022 )	+	Accounts Payable (Q: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2022 )	*	Days in Period
=	( (5.696	+	16.008)	/	2 )	/	25.002	*	365 / 2
=	10.852					/	25.002	*	365 / 2
=	79.21

Quantum Genomics Days Payable Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (STU:2QG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (STU:2QG) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (STU:2QG) Headlines

No Headlines